Risk of stroke following herpes zoster: A self-controlled case-series study

Clinical Infectious Diseases

Volumn 58, Issue 11, 2014, Pages 1497-1503

  Langan, Sinéad M ^a   Minassian, Caroline ^a   Smeeth, Liam ^a   Thomas, Sara L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Herpes zoster; Self controlled case series study; Stroke

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AGED; ARTICLE; CASE STUDY; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; FEMALE; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RISK; RISK ASSESSMENT; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM; VERY ELDERLY; AGE; COMPLICATION; GREAT BRITAIN; STROKE; TIME FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; GREAT BRITAIN; HERPES ZOSTER; HUMANS; INCIDENCE; MALE; RISK ASSESSMENT; STROKE; TIME FACTORS;

EID: 84900418877     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu098     Document Type: Article

References (31)

1. Ridker PM, Silvertown JD. Inflammation, C-reactive protein, and atherothrombosis. J Periodontol 2008; 79(8 suppl):1544-51.
2. Emsley HC, Hopkins SJ. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol 2008; 7:341-53.
3. Warren-Gash C, Smeeth L, Hayward A. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review. Lancet Infect Dis 2009; 9:601-10.
4. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007; 82:1341-9.
5. Johnson RW, Bouhassira D, Kassianos G, Leplige A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37.
6. Brisson M, Edmunds W, Law B, et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001; 127:305-14.
7. Gilden D, Cohrs RJ, Mahalingam R, Nagel MA. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol 2009; 8:731-40.
8. Nogueira RG, Sheen VL. Images in clinical medicine. Herpes zoster ophthalmicus followed by contralateral hemiparesis. N Engl J Med 2002; 346:1127.
9. Kumar A, Mollison L. Cerebral infarction following thoracic herpes zoster. Australas J Dermatol 1993; 34:113-4.
10. Kang J, Ho J, Chen Y, Lin H. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke 2009; 40:3443-8.
11. Lin HC, Chien CW, Ho JD. Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study. Neurology 2010; 74:792-7.
12. Nagel M, Ortiz G. Does herpes zoster ophthalmicus increase the risk of stroke? Neurology 2010; 74:788-9.
13. General Practice Research Database. Available at: http://www.gprd.com/ products/database.asp. Accessed 14 July 2011.
14. Herrett E, Thomas S, Schoonen W, Smeeth L, Hall A. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69:4-14.
15. Smeeth L, Cook C, Fombonne E, et al. MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 2004; 364:963-9.
16. Smeeth L, Thomas S, Hall A, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351:2611-8.
17. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367:1075-9.
18. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51:228-35.
19. Lewis J, BilkerW, Weinstein R, Strom B. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005; 14:443-51.
20. Minassian C, D?Aiuto F, Hingorani AD, Smeeth L. Invasive dental treatment and risk for vascular events: a self-controlled case series. Ann Intern Med 2010; 153:499-506.
21. Tata L, West J, Harrison T, Farrington P, Smith C, Hubbard R. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58:835-9.
22. Sreenivasan N, Basit S,Wohlfahrt J, et al. The short-and long-term risk of stroke after herpes zoster-a nationwide population-based cohort study. PLoS One 2013; 8:e69156.
23. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010; 30:5-6, 8-9.
24. Forbes HJ, Thomas SL, Smeeth L, Langan SM. Prescription of antiviral therapy after herpes zoster in general practice: who receives therapy? Br J Gen Pract 2012; 62:e808-14.
25. Dworkin RH, Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clin Infect Dis 2007; 44(suppl 1):S1-26.
26. Tyring S, Barbarash RA, Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123:89-96.
27. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: the risks of stroke, cardiovascular disease, and death in practice. Neurology 2004; 62:563-8.
28. Gibbs RG, Newson R, Lawrenson R, Greenhalgh RM, Davies AH. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke 2001; 32:1085-90.
29. OpsteltenW, van Loon AM, Schuller M, et al. Clinical diagnosis of herpes zoster in family practice. Ann Fam Med 2007; 5:305-9.
30. Donahue J, Choo P, Manson J, Platt R. The incidence of herpes zoster. Arch Intern Med 1995; 155:1605-9.
31. Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol 2011; 174:1054-61.